138 related articles for article (PubMed ID: 14993408)
1. Pharmaceutical branding: identity, individuality, and illness.
Greenslit N
Mol Interv; 2002 Oct; 2(6):342-5. PubMed ID: 14993408
[No Abstract] [Full Text] [Related]
2. Pharmaceutical marketing and the new social media.
Greene JA; Kesselheim AS
N Engl J Med; 2010 Nov; 363(22):2087-9. PubMed ID: 21105789
[No Abstract] [Full Text] [Related]
3. Direct to consumer marketing: advertising directly to consumers may affect patients' safety.
Hochhauser M
BMJ; 2005 Apr; 330(7496):906. PubMed ID: 15831888
[No Abstract] [Full Text] [Related]
4. Direct to consumer marketing: switch to over the counter can become indirect advertising directly to consumers.
Duerden M; Walley T
BMJ; 2005 Apr; 330(7496):906. PubMed ID: 15831889
[No Abstract] [Full Text] [Related]
5. Depression and consumption: psychopharmaceuticals, branding, and new identity practices.
Greenslit N
Cult Med Psychiatry; 2005 Dec; 29(4):477-502. PubMed ID: 16699877
[TBL] [Abstract][Full Text] [Related]
6. [Promoting research and graduate education by the pharmaceutical industry--scientific progress or marketing strategy?].
Eckardt VF
Z Gastroenterol; 1999 Jul; Suppl 2():19-27. PubMed ID: 10472695
[No Abstract] [Full Text] [Related]
7. The changing face of pharmaceutical advertising. A look at medical journals reveals a new era in advertising.
Weeks WB; Wallace AE; Kimberly BC
Mark Health Serv; 2001; 21(3):27-30. PubMed ID: 11525138
[No Abstract] [Full Text] [Related]
8. Fluoxetine treatment of premenstrual syndrome.
Metz A
J Clin Psychiatry; 1990 Jun; 51(6):260. PubMed ID: 2347868
[No Abstract] [Full Text] [Related]
9. Gendering the migraine market: do representations of illness matter?
Kempner J
Soc Sci Med; 2006 Oct; 63(8):1986-97. PubMed ID: 16790309
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine treatment of premenstrual syndrome.
Pies RW
J Clin Psychiatry; 1990 Aug; 51(8):348. PubMed ID: 2380164
[No Abstract] [Full Text] [Related]
11. Does brand differentiate pharmaceuticals?
Bednarik J
Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
[TBL] [Abstract][Full Text] [Related]
12. Direct-to-consumer advertising policy in Australia: realism in whose interests?
Vitry A; Mintzes B; Lexchin J
Intern Med J; 2007 Sep; 37(9):665-6; author reply 666-7. PubMed ID: 17714212
[No Abstract] [Full Text] [Related]
13. [Premenstrual syndrome, drug advertising and sex discrimination].
Philip J
Ugeskr Laeger; 1980 Mar; 142(12):783-4. PubMed ID: 7189307
[No Abstract] [Full Text] [Related]
14. The long and winding road.
Nat Rev Drug Discov; 2005 Jun; 4(6):443. PubMed ID: 15959946
[No Abstract] [Full Text] [Related]
15. Social reactions to Valium and Prozac: a cultural lag perspective of drug diffusion and adoption.
Marshall KP; Georgievskava Z; Georgievsky I
Res Social Adm Pharm; 2009 Jun; 5(2):94-107. PubMed ID: 19524858
[TBL] [Abstract][Full Text] [Related]
16. Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews.
Kyle GJ; Nissen L; Tett S
Clin Ther; 2008 Dec; 30(12):2461-73. PubMed ID: 19167604
[TBL] [Abstract][Full Text] [Related]
17. But first, call your drug company: the doctor-patient relationship is being replaced by a drug marketer-patient bond.
Weissman RX
Am Demogr; 1998 Oct; 20(10):27-30. PubMed ID: 10346668
[No Abstract] [Full Text] [Related]
18. Pharmaceutical industry marketing: understanding its impact on women's health.
Sufrin CB; Ross JS
Obstet Gynecol Surv; 2008 Sep; 63(9):585-96. PubMed ID: 18713478
[TBL] [Abstract][Full Text] [Related]
19. Branding your practice: twelve practical steps to creating lifelong patient relationships.
Neely MH
J Med Pract Manage; 2005; 20(5):266-70. PubMed ID: 15921141
[TBL] [Abstract][Full Text] [Related]
20. Big biotech embraces direct-to-consumer advertising.
Katsnelson A
Nat Biotechnol; 2005 Oct; 23(10):1193. PubMed ID: 16211045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
